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Dear Editor, 
Antipsychotic-induced1 amenorrhea is a serious concern among 
premenopausal women suffering from mental disorders. Among 
many women, menstruation is a symbol of femininity that indicates 
the ability to become pregnant naturally, or is a basis to determine if 
they are menopausal2. Some patients believe the lack of menstruation 
signifies menopause and contributes to emotional instability or 
aggravation of their mental disorder. Patients with amenorrhea often 
seek help from gynecologists to induce menstruation. Peuskens et 
al.3 reported that amenorrhea occurred in 22-50% of women treated 
with antipsychotics. The prevalence of menstrual irregularities and 
amenorrhea is considered to be 15-97% in women receiving therapy 
for a psychotic disorder4. It is also common for patients to discontinue 
antipsychotics due to amenorrhea, which in turn triggers relapses. 
I will discuss two cases here: a patient with schizoaffective 
disorder and another with bipolar I, manic episodes with psychotic 
features. Both patients achieved full remission of psychotic symptoms, 
but wanted to switch medications due to lack of menstruation and 
weight gain. Both patients were middle-aged women in their 40s, 
with multiple past records of discontinuing their medication that 
triggered relapses and led to hospitalization. Therefore, I prescribed 
aripiprazole to facilitate a gradual process of switching medications. 
Table 1 summarizes the history of past medications, medication 
switching process, and results of therapy for the two patients. 
Notably, amenorrhea does not only occur among patients with 
hyperprolactinemia, but also among premenopausal patients with 
normal blood prolactin levels, even when using multi-acting receptor 
targeted antipsychotics (MARTAs), which have an extremely low 
probability of causing amenorrhea. 
Among antipsychotics, hyperprolactinemia is most commonly 
induced by sulpiride, amisulpride, risperidone, and paliperidone. 
Paparrigopoulos et al. found that the prevalence rate of 
hyperprolactinemia induced by amisulpride was 100%, and this was 
observed more in women than in men5. The prevalence of menstrual 
side effects such as amenorrhea in patients on risperidone is reported 
to be 1-10%6. In addition, serotonin-dopamine antagonists (SDAs) 
are more likely to induce hyperprolactinemia than MARTAs. 
Psychiatrists thus often use MARTAs, such as olanzapine and 
clozapine1, to treat female psychotic patients with amenorrhea. 
However, it has been reported that even olanzapine may lead to 
hyperprolactinemia7.
Aripiprazole is regarded as a second- or third-generation 
antipsychotic, mainly because it provides a control mechanism for 
the dopamine “see-saw”. It reduces the dopaminergic neuron activity 
in brain regions with dopamine hyperactivity, while increasing the 
dopaminergic neuron activity in regions with hypoactivity, thereby 
reducing the number of side effects; regarding reduced side effects, 
SSRI: selective serotonin reuptake inhibitors; NDRI: norepinephrine-dopamine reuptake inhibitor; 
NaSSA: noradrenergic and specific serotonergic antidepressants.
Figure 1. Summary of the clinical algorithm used patients are suspected 
of antipsychotic-induced amenorrhea7.
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the resolution of hyperprolactinemia has attracted the most attention. 
Aripiprazole can be used to resolve hyperprolactinemia induced by 
risperidone8, amisulpride, and ziprasidone9. However, the use of 
aripiprazole to resolve MARTA-induced amenorrhea has rarely been 
reported, especially in amenorrhea without hyperprolactinemia. 
Some may believe that since aripiprazole can reduce amenorrhea, we 
should attempt to use it in the early stages of disease onset in women. 
It should be noted that in Case 2, aripiprazole was used during the 
early stages of disease onset. However, due to its slow antimanic 
effect, it was combined with zotepine after four weeks, and was 
only completely replaced by zotepine (100 mg/d) after eight weeks, 
followed by a switch to aripiprazole after the unexpected occurrence 
of amenorrhea. In both cases, full D2 antagonists were used initially 
for rapid therapeutic effect until full remission of the mental disorder, 
and then were successfully replaced by aripiprazole completely over 
one to two months. This was a viable therapeutic strategy.
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Table 1. Summary of past medications, medication switching process, and results of therapy for the two patients
Patient 1 Patient 2
Diagnosis Schizoaffective disorder Bipolar I, manic episode with psychotic features
Age 44 43
Past medications 2011  Risperidone 2 mg/d
2013/1  Zotepine 100 mg/d 
2013/8 Olanzapine 10 mg/d + sertraline 50 mg/d
 (body weight increased 20 kg)
2014/9  Risperidone 3 mg/d 
2014/12  Began to visit gynecologist every month till 2015.10.14
2015.9.16  Last prescription at gynecology out-patient department
 
Above are the past discharge medications, out-patient medications and 
gynecological follow-up visits
2009 Lithium 900 mg/d+
 Valproic acid 900 mg/d+ Risperidone 4 mg/d 
2010/3 Lithium 600 mg/d+ 
 Valproic acid 1000 mg/d+ Risperidone 3 mg/d
2010/7 Valproic acid 750 mg/d+
 Risperidone 3 mg/d
2013 Valproic acid 500 mg/d+ 
 Risperidone 3 mg/d
2014 Lithium 600 mg/d +
 Risperidone 3 mg/d
Above is the past discharge medication list.
Below are the medications prescribed during this hospitalization
2016/5/13 Aripiprazole 30 mg/d
2016/5/25 Aripiprazole 30 mg/d
 Dogmatyl 200 mg/d
2016/6/8 Aripiprazole 30 mg/d
 Zotepine 50 mg/d
2016/7/4 Zotepine 75 mg/d+
 Lithium 900 mg/d
2016/7/5 Zotepine 100 mg/d+
 Lithium 900/d      
2016/7/13 Zotepine 100 mg/d+
 Lithium 600 mg/d
Medication switching 
process
2015.8.19  LMP (last menstrual period)
2015.8.29      PRL (prolactin) = 92.92 ng/ml
2015.10.22     Risperidone 2 mg/d+
               Aripiprazole 10 mg/d
                X 21 days
2015.11.12     Risperidone 1 mg/d+
               Aripiprazole 20 mg/d
                X 14 days
2015.11.26     Aripiprazole 20 mg/d
               (delete risperidone) 
2015.12.16     PRL = 6.93 ng/nl
2016.2.4       PRL = 6.65 ng/nl
2016.8.7 LMP
2016.10.18 Zotepine 50 mg/d+
 Aripiprazole 10 mg/d+
 Lithium 600 mg/d   
2016.10.19 PRL = 8.01 ng/ml 
2016.10.26 Aripiprazole 20 mg/d+
 Lithium 600 mg/d (delete zotepine) 
2016.11.4 PRL = 5.42 ng/ml
2016.11.14 Norethisterone (5) 1#tid x 3 days (progestin challenge)
2016.11.15 Normal CEA/CA125; CEA (carcinoembryonic antigen); 
 CA (carbohydrate antigen) 
 r/o ovarian cancer 
Result 2015.12.15 Menstruation resumed naturally without assistance from 
gynecological drugs, and body weight decreased by 3-4 kilograms 
2016. 11.22 Menstruation resumed 
In conclusion, when using antipsychotics among premenopausal 
women, we should consider the possibility of self-discontinuation 
of medications due to amenorrhea. Hence, after achieving rapid 
symptom alleviation using non-aripiprazole antipsychotics, 
the patient should be switched to aripiprazole, which prevents 
amenorrhea and may also achieve weight loss. Further clinical studies 
are needed to explore possible solutions to amenorrhea induced by 
antipsychotics. Figure 1 summarizes the clinical algorithm used 
when patients are suspected of antipsychotic-induced amenorrhea7.
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